The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
Status:
Completed
Trial end date:
2020-01-21
Target enrollment:
Participant gender:
Summary
The goal of this study is to assess the tolerability, pharmacokinetics and antiviral activity
of HEC74647 in HCV treatment naïve subjects with genotypes 1-6.